Marsh McLennan has reported attributable net income of $1.21bn for the second quarter of 2025 (Q2 2025), a 7.6% increase from $1.12bn a year ago.
The company’s diluted net income per share rose by 8% to $2.45, while operating income grew by 11.8% to $1.83bn.
The insurer’s consolidated revenue for the quarter stood at $6.97bn, a 12% increase from Q1 2024.
John Doyle, president and CEO, said: “We had another solid quarter with 12% revenue growth reflecting continued momentum across our business and the contribution from acquisitions.
“Our performance demonstrates the enduring value we provide to clients, as well as our consistent execution in a complex and dynamic environment.”
Revenues in the Risk & Insurance Services segment reached $4.6bn, a 15% increase.
Within this segment, Marsh, a unit of Marsh McLennan, contributed with revenue of $3.8bn, up 18% year-on-year. Guy Carpenter’s revenue reached $677m, an increase of 7%.
The company’s performance was also strong on a regional basis, with underlying revenue in the US/Canada region growing by 4%.
International operations saw a 7% increase in underlying revenue, including an 8% rise in Europe, the Middle East and Africa, a 4% increase in Asia-Pacific and a 3% uptick in Latin America.
Marsh McLennan reported the repurchase of 1.4 million shares of stock at a cost of $300m during Q2 2025.
For the six-month period ending 30 June 2025, the company’s net income was $2.59bn, as against $2.52bn a year ago.
Revenue increased to $14.03bn from $12.69bn in the first half of 2024 (H1 2024).
In Q1 2025, Marsh McLennan reported net income of $1.38bn, down from $1.4bn in the same quarter of the previous year.
“Marsh McLennan net income surges 7.6% to $1.2bn in Q2 2025 ” was originally created and published by Life Insurance International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
